Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. In expanding its drug development efforts in the field of cancer through its proprietary targeted cancer programs, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies.
Type
Public
HQ
Lexington, US
Founded
2000
Employees
44 (est)
Curis was founded in 2000 and is headquartered in Lexington, US

Curis Locations

Lexington, US

Curis Metrics

Curis Summary

Market capitalization

$416 M

Closing share price

$3.06
Curis's latest market capitalization is $416 M.

Curis Market Value History

Curis Company Life

You may also be interested in